SP Gorantla

SP Gorantla

Technische Universität München - München / Germany
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1782213
Technical University of Munich
person_outline SP Gorantla's MOST POPULAR ARTICLES
1-) Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasmsA Prestipino, AJ Emhardt, K Aumann, D O’Sullivan, SP Gorantla, ...Science translational medicine 10 (429), eaam7729, 20181502018
2-) The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107.N Von Bubnoff, SH Gorantla, RK Kancha, F Lordick, C Peschel, J DuysterLeukemia: official journal of the Leukemia Society of America, Leukemia …, 2005842005
3-) The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib)N von Bubnoff, SP Gorantla, S Thöne, C Peschel, J DuysterBlood 107 (12), 4970-4972, 2006672006
4-) Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivoC Rummelt, SP Gorantla, M Meggendorfer, A Charlet, C Endres, ...Leukemia 35 (7), 2017-2029, 2021372021
5-) The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA …N Von Bubnoff, SP Gorantla, RA Engh, TM Oliveira, S Thöne, E Åberg, ...Oncogene 30 (8), 933-943, 2011342011